Managing fatigue: Clinical correlates, assessment procedures and therapeutic strategies

International MS Journal

Volumn 17, Issue 1, 2010, Pages 28-34

  Penner, I K ^a,b   Calabrese, P ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Fatigue; Fatigue assessment; Fatigue treatment; Multiple sclerosis

Indexed keywords

4 AMINOPYRIDINE; AMANTADINE; MODAFINIL; PEMOLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED RELEASE FORMULATION; DEPRESSION; DISEASE DURATION; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; EXERCISE; FATIGUE; HUMAN; INSOMNIA; MENTAL PERFORMANCE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHYSICAL ACTIVITY; QUALITY OF LIFE; RELAXATION TRAINING; SEIZURE; SKIN TINGLING; SLEEP DISORDER;

DEPRESSION; DEPRESSIVE DISORDER; FATIGUE; HUMANS; MULTIPLE SCLEROSIS; QUALITY OF LIFE;

EID: 77954835373     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Fisk JD, Pontefract A, Ritvo PG et al. The impact of fatigue on patients with multiple sclerosis. Canadian J Neurol Sci 1994;21: 9-14
2. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehab 1984;65: 135-138
3. Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol 2001;248: 174-179
4. Whitaker J, Mitchell G. Clinical features of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple Sclerosis Clinical and Pathogenetic Basis. London: Chapman & Hall Medical; 1997. p. 3-19
5. Djaldetti R, Ziv I, Achiron A, Melamed E. Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment. Neurology 1996;46: 632-635
6. Miller RG, Green AT, Moussavi RS et al. Excessive muscular fatigue in patients with spastic paraparesis. Neurology 1990;40:1271-1274.
7. Dickinson CJ. Chronic fatigue syndrome -aetiological aspects. Eur J Clin Invest 1997;27: 257-267
8. Schwartz RB, Garada BM, Komaroff AL. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. Am J Roentgenology 1994;162:935-941
9. Roelcke U, Kappos L, Lechner-Scott J et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997;48: 1566-1571
10. Mowry EM, Beheshtian A, Waubant E et al. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology 2009;72: 1760-1765
11. Sepulcre J, Masdeu JC, Goni J et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler 2009;15: 337-344
12. Bertolone K, Coyle PK, Krupp LB, Doschler C. Cytokine correlates of fatigue in multiple sclerosis. Neurology 1993;343: 356.
13. Chao CC, DeLa Hunt M, Hu S et al. Immunologically mediated fatigue: a murine model. Clin Immunol Immunopath 1992;64: 161-165
14. Heesen C, Gold S, Raji A et al. Cognitive impairment correlates with hypothalamic-pituitaryadrenal axis dysregulation in MS. Psychoneuroendocrin 2002;27: 507-517
15. Filippi M, Rocca MA, Colombo B et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. NeuroImage 2002;15: 559-567
16. Krupp LB, Coyle PK, Doscher C et al. Fatigue therapy in multiple sclerosis: Results of a double blind, randomised parallel trial of amantadine, pemoline and placebo. Neurology 1995;45: 1956-1961
17. Colosimo C, Millefiorini E, Grasso MG et al. Fatigue in MS is associated with specific clinical features. Acta Neurologica Scandinavica 1995;92: 353-355
18. Bergamaschi R, Romani A, Versino M et al. Clinical aspects of fatigue in multiple sclerosis. Funct Neurol 1997;12: 247-251
19. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988;45: 435-437
20. Bakshi R, Shaikh ZA, Miletich R et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scleros 2000; 6: 181-185
21. Vercoulen JH, Hommes OR, Swanink CM et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996;53: 642-649
22. Morrow SA, Weinstock-Guttman B, Munschauer FE et al. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: Cross-sectional and longitudinal analysis. Mult Scleros 2009;15(8): 998-1005
23. Moller A, Wiedemann G, Rohde U et al. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatrica Scandinavica 1994;89: 117-121
24. Bakshi R, Miletich RS, Henschel K et al. Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients. Neurology 1999;53: 1151-1153
25. Colombo B, Martinelli Boneschi F, Rossi P et al. MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 2000;247: 506-509
26. Mainero C, Faroni J, Gasperini C et al. Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 1999;246: 454-458
27. Van der Werf SP, Jongen PJ, Lycklama a Nijeholt GJ et al. Fatigue in multiple sclerosis: Interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci 1998;160: 164-170
28. Marrie RA, Fisher E, Miller DM et al. Association of fatigue and brain atrophy in multiple sclerosis. J Neurol Sci 2005;228: 161-166
29. Tedeschi G, Dinacci D, Lavorgna L et al. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci 2007;263: 15-19
30. Codella M, Rocca MA, Colombo B et al. A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol 2002;249: 535-537
31. Tartaglia MC, Narayanan S, Francis SJ et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 2004;61: 201-207
32. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetylaspartate with monoclonal antibodies. Neuroscience 1991;45: 37-45
33. Matthews PM, Arnold DL. Magnetic resonance imaging of multiple sclerosis: New insights linking pathology to clinical evolution. Curr Opin Neurol 2001;14: 279-287
34. Leocani L, Colombo B, Magnani G et al. Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement -EEG evidence. NeuroImage 2001;13: 1186-1192
35. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America; 1998.
36. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46: 1121-1123
37. Penner IK, Raselli C, Stöcklin M et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler 2009;15:1509-1517
38. Murray TJ. Amantadine therapy for fatigue in MS. Canadian J Neurol Sci 1985;12: 251-254
39. Cohen RA, Fisher M. Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 1989;46: 676-680
40. Pucci E, Branas P, D'Amico R, et al. Amantadine for fatigue in multiple sclerosis. Cochrane Database of Systematic Reviews 2007;24: CD002818.
41. Lange R, Volkmer M, Heesen C, Liepert J. Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 2009;256: 645-650
42. Brioschi A, Gramigna S, Werth E et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol 2009;62: 243-9
43. Rammohan KW, Rosenberg JH, Lynn DJ et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiat 2002;72: 179-183
44. Zifko UA, Rupp M, Schwarz S et al. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 2002;249: 983-987
45. Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M; French Modafinil Study Group. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 2005 Apr 12;64(7): 1139-1143
46. Weinshenker BG, Penman M, Bass B, et al. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992;42: 1468-1471
47. Schwid, SR, Murray, JT. Treating fatigue in patients with MS: one step forward, one step back. Neurology 2005;64: 1111-1112
48. Rossini PM, Pasqualetti P, Pozzilli C et al. Fatigue in progressive multiple sclerosis: results of a randomized, doubleblind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scleros 2001;7: 354-358
49. Goodman AD, Cohen JA, Cross A et al. Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, doseranging study. Mult Scleros 2007;13: 357-368
50. Schwid SR, Petrie MD, Murray R et al. A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology 2003;60: 1955-1960
51. Meyer-Heim A, Rothmeier M, Weder M et al. Advanced lightweight cooling-garment technology: functional improvements in thermosensitive patients with multiple sclerosis. Mult Scleros 2007;13: 232-237
52. Oken BS, Kishiyama S, Zajdel D et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004;62:2058-2064